330 related articles for article (PubMed ID: 11409907)
1. Non-infectious complications of transfusion therapy.
Perrotta PL; Snyder EL
Blood Rev; 2001 Jun; 15(2):69-83. PubMed ID: 11409907
[TBL] [Abstract][Full Text] [Related]
2. Noninfectious serious hazards of transfusion.
Hendrickson JE; Hillyer CD
Anesth Analg; 2009 Mar; 108(3):759-69. PubMed ID: 19224780
[TBL] [Abstract][Full Text] [Related]
3. Reducing the risk of bacterial contamination of cellular blood components.
Blajchman MA
Dev Biol (Basel); 2000; 102():183-93. PubMed ID: 10794105
[TBL] [Abstract][Full Text] [Related]
4. [Risk of immunization to blood cells and diagnostic and therapeutic implications].
Kiefel V
Beitr Infusionsther; 1993; 31():44-51. PubMed ID: 7693263
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte-reduced blood components: patient benefits and practical applications.
Higgins VL
Oncol Nurs Forum; 1996 May; 23(4):659-67. PubMed ID: 8735324
[TBL] [Abstract][Full Text] [Related]
6. Incidence and significance of the bacterial contamination of blood components.
Blajchman MA
Dev Biol (Basel); 2002; 108():59-67. PubMed ID: 12220143
[TBL] [Abstract][Full Text] [Related]
7. Risks of blood transfusion and their prevention.
Sandler SG; Yu H; Rassai N
Clin Adv Hematol Oncol; 2003 May; 1(5):307-13. PubMed ID: 16224428
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
Bux J
Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
[TBL] [Abstract][Full Text] [Related]
9. Noninfectious risks and new trends in transfusion practice.
Walker RH
J Fla Med Assoc; 1993 Jan; 80(1):37-8. PubMed ID: 8436931
[TBL] [Abstract][Full Text] [Related]
10. Noninfectious serious hazards of transfusion.
Janatpour K; Holland PV
Curr Hematol Rep; 2002 Nov; 1(2):149-55. PubMed ID: 12901137
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
12. Risks associated with transfusion of cellular blood components in Canada.
Kleinman S; Chan P; Robillard P
Transfus Med Rev; 2003 Apr; 17(2):120-62. PubMed ID: 12733105
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-related acute lung injury (TRALI).
Roberts GH
Clin Lab Sci; 2004; 17(3):133-5. PubMed ID: 15314887
[TBL] [Abstract][Full Text] [Related]
14. Blood transfusion risks and alternative strategies in pediatric patients.
Lavoie J
Paediatr Anaesth; 2011 Jan; 21(1):14-24. PubMed ID: 21155923
[TBL] [Abstract][Full Text] [Related]
15. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
[TBL] [Abstract][Full Text] [Related]
16. Transfusion in transplant patients: the good, the bad, and the ugly.
Klein HG
J Heart Lung Transplant; 1993; 12(1 Pt 1):S7-12. PubMed ID: 8443186
[TBL] [Abstract][Full Text] [Related]
17. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB;
Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033
[TBL] [Abstract][Full Text] [Related]
18. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications.
Spinella PC
Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261
[TBL] [Abstract][Full Text] [Related]
19. Transfusion risks and limitations.
Mercuriali F; Inghilleri G
Minerva Anestesiol; 1999 May; 65(5):286-92. PubMed ID: 10389406
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
Arndt PA; Garratty G
Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
